glp-1 dementia news Adults whose type 2 diabetes was treated with receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective In the News: FDA Approves

To lose weight, you can make lifestyle changes to diet and exercise, investigate obstacles to weight loss, and join a group weight loss program that keeps your individual needs in mind

Specific complaints include the use of stock images presented as real customer results, and fake profiles claiming dramatic weight loss

Each medication is prepared by licensed 503A compounding pharmacies using pharmaceutical-grade ingredients and sterile preparation protocols

Read more in The Health Benefits of Berberine

This has led to the identification of a metabolic subtype of depression, marked by IR and clinical features such as anhedonia, low energy, cognitive slowing, and poor response to first-line antidepressant treatments [25,33]